Results 161 to 170 of about 42,543 (244)

Recent advances in immunotherapy for breast cancer. [PDF]

Discov Oncol
Guo Y, Zheng G, Fan Y, Li L, Sun Y.
europepmc   +1 more source

Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients

, 1997
Michael A. Nalesnik, A S Rao, Adriana Zeevi, John J. Fung, S. Pharn, Hiro Furukawa, Albin Gritsch, George Klein, Thomas E. Starzl   +8 more
openalex   +2 more sources

A Review of Immunotherapy in Renal Cell Carcinoma: Current Landscape and Future Directions. [PDF]

Cancers (Basel)
Peshin S, Dharia A, Moka N, Skelton WP.
europepmc   +1 more source

Recent Advances in Immunotherapy for Melanoma: Perspectives on the Development of Novel Treatments: A Mini Review. [PDF]

Cancers (Basel)
Muto Y, Fujimura T, Asano Y.
europepmc   +1 more source

Immunocytokines in cancer immunotherapy: opportunities and challenges. [PDF]

Front Oncol
Wang S, Yao L, Cai J, Gao H, Zhou F.
europepmc   +1 more source

Therapeutic potential of adenosine receptor modulators in cancer treatment. [PDF]

RSC Adv
Maity P, Ganguly S, Deb PK.
europepmc   +1 more source

Current status of cytokine-induced killer cells and combination regimens in breast cancer. [PDF]

Front Immunol
Jiang Y, Qiu J, Ye N, Xu Y.
europepmc   +1 more source

Natural killer cell-based immunotherapy for cancer. [PDF]

J Immunol
Ma S, Yu J, Caligiuri MA.
europepmc   +1 more source

Adoptive immune cell therapy for colorectal cancer. [PDF]

Front Immunol
Liu C, Liu N, Zhang T, Tu Y.
europepmc   +1 more source

Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation. [PDF]

Sci Rep
Mohseni R, Mahdavi Sharif P, Behfar M, Shojaei S, Shoae-Hassani A, Jafari L, Khosravi A, Nikfetrat Z, Hamidieh AA.   +8 more
europepmc   +1 more source